Literature DB >> 22511589

Primary osteoporosis without features of OI in children and adolescents: clinical and genetic characteristics.

Christine M Laine1, Dror Koltin, Miki Susic, Talia L Varley, Alan Daneman, Rahim Moineddin, William G Cole, Outi Mäkitie, Etienne Sochett.   

Abstract

Our aim was to characterize clinical findings and familial associations, and to examine candidate genes for disease-causing mutations in a cohort of children suffering from primary osteoporosis without features of osteogenesis imperfecta. Patients with osteoporosis and their nuclear families were studied. Medical history was reviewed. Calcium homeostasis parameters were measured and spinal radiographs obtained. BMD was determined by DXA for patients, parents and siblings. LRP5, LRP6, and PTHLH genes were sequenced. Twenty-seven patients (14 males) from 24 families were recruited. Median age at presentation was 10.1 years (range 3.3-15.6 years). One-third of the children had at least one parent with a BMD below the expected range for age. LRP5, LRP6, and PTHLH showed no causative mutations. Four polymorphisms in LRP5 were overrepresented in patients; the minor allele frequency of Q89R, V667M, N740N, and A1330V was significantly higher than in controls. Age of onset, clinical severity, and inheritance patterns are variable in children with primary osteoporosis. Several patients had evidence suggestive of familial transmission. The underlying genetic factors remain to be elucidated.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511589     DOI: 10.1002/ajmg.a.35278

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Authors:  Gretl Hendrickx; Eveline Boudin; Wim Van Hul
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

2.  LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients.

Authors:  M Bernardes; C Durães; A Oliveira; M J Martins; R Lucas; L Costa; J G Pereira; I Ramos; J C Machado; F Simões-Ventura
Journal:  Osteoporos Int       Date:  2018-07-17       Impact factor: 4.507

3.  Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography.

Authors:  Justine Bacchetta; Katherine Wesseling-Perry; Vicente Gilsanz; Barbara Gales; Renata C Pereira; Isidro B Salusky
Journal:  Pediatr Rheumatol Online J       Date:  2013-02-19       Impact factor: 3.054

Review 4.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

5.  Diagnostic yield of bone fragility gene panel sequencing in children and young adults referred for idiopathic primary osteoporosis at a single regional reference centre.

Authors:  Coline Rouleau; Margaux Malorie; Corinne Collet; Valérie Porquet-Bordes; Isabelle Gennero; Sanaa Eddiry; Michel Laroche; Jean Pierre Salles; Guillaume Couture; Thomas Edouard
Journal:  Bone Rep       Date:  2022-02-23

6.  Assessing Osteoporosis in the Young Adult.

Authors:  Wong Sze Choong; Stephen Gallacher; Syed Faisal Ahmed
Journal:  Eur Endocrinol       Date:  2015-04-11

7.  Autism and heritable bone fragility: A true association?

Authors:  Meena Balasubramanian; Rebecca Jones; Elizabeth Milne; Charlotte Marshall; Paul Arundel; Kath Smith; Nicholas J Bishop
Journal:  Bone Rep       Date:  2018-04-18

8.  Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.

Authors:  Ralf Oheim; Elena Tsourdi; Lothar Seefried; Gisela Beller; Max Schubach; Eik Vettorazzi; Julian Stürznickel; Tim Rolvien; Nadja Ehmke; Alena Delsmann; Franca Genest; Ulrike Krüger; Tomasz Zemojtel; Florian Barvencik; Thorsten Schinke; Franz Jakob; Lorenz C Hofbauer; Stefan Mundlos; Uwe Kornak
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.